DS 1971

Drug Profile

DS 1971

Alternative Names: DS-1971; DS-1971a

Latest Information Update: 07 Oct 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Daiichi Sankyo Inc
  • Class Analgesics
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Phase I Pain

Most Recent Events

  • 26 Sep 2016 Daiichi Sankyo terminates a phase II trial prior to enrolment for Pain in Japan (JapicCTI163193)
  • 26 Jul 2016 Daiichi Sankyo withdraws a phase II trial prior to enrolment in Neuropathic pain (associated with diabetes) in USA (NCT02673866)
  • 09 Mar 2016 Daiichi Sankyo plans a phase II trial for Pain in Japan (JapicCTI163193)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top